Entinostat, a histone deacetylase inhibitor, increases the population of IL-10+ regulatory B cells to suppress contact hypersensitivity

키워드

참고문헌 (34)

1. Neta R, "Specific suppression of delayed hypersensitivity : the possible presence of a suppressor B cell in the regulation of delayed hypersensitivity", J Immunol, 113, pp.1716~1725 (1974)
2. Mizoguchi A, "Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation", Immunity, 16, pp.219~230 (2002)
3. Rosser EC, "Regulatory B cells : origin, phenotype, and function", Immunity, 42, pp.607~612 (2015)
4. Junghee Lee, "Epigenetic modification is linked to Alzheimer’s disease: is it a maker or a marker?", BMB Reports, 43(10), pp.649~655 (2010), 생화학분자생물학회
5. Xu WS, "Histone deacetylase inhibitors : molecular mechanisms of action", Oncogene, 26, pp.5541~5552 (2007)
6. Hull EE, "HDAC inhibitors as epigenetic regulators of the immune system : impacts on cancer therapy and inflammatory diseases", Biomed Res Int, 2016, pp.8797206~ (2016)
7. Tsuji G, "Histone deacetylase 6 inhibition impairs effector CD8T-cell functions during skin inflammation", J Allergy Clin Immunol, 135, pp.1228~1239 (2015)
8. Shi YL, "Histone deacetylases inhibitor Trichostatin A ameliorates DNFB-induced allergic contact dermatitis and reduces epidermal Langerhans cells in mice", J Dermatol Sci, 68, pp.99~107 (2012)
9. Do A, "An HDAC6 inhibitor confers protection and selectively inhibits B-cell infiltration in DSS-induced colitis in mice", J Pharmacol Exp Ther, 360, pp.140~151 (2017)
10. White CA, "Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses", J Immunol, 193, pp.5933~5950 (2014)
11. Yanaba K, "The development and function of regulatory B cells expressing IL-10(B10 cells). requires antigen receptor diversity and TLR signals", J Immunol, 182, pp.7459~7472 (2009)
12. Wang B, "CD4+ Th1and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity", J Immunol, 165, pp.6783~6790 (2000)
13. Peiser M, "Role of Th17 cells in skin inflammation of allergic contact dermatitis", Clin Dev Immunol, 2013, pp.261037~ (2013)
14. Ring S, "CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions through a CD39, adenosine-dependent mechanism", J Allergy Clin Immunol, 123, pp.1287~1296 (2009)
15. Rosser EC, "Regulatory B cells are induced by gut microbiota-driven interleukin-1βand interleukin-6 production", Nat Med, 20, pp.1334~1339 (2014)
16. 김혁순, "Autocrine stimulation of IL-10 is critical to the enrichment of IL-10-producing CD40hiCD5+ regulatory B cells in vitro and in vivo", BMB Reports, 48(1), pp.54~59 (2015), 생화학분자생물학회
17. Tan CH, "Contact dermatitis : allergic and irritant", Clin Dermatol, 32, pp.116~124 (2014)
18. Peiser M, "Allergic contact dermatitis : epidemiology, molecular mechanisms, in vitro methods and regulatory aspects", Cell Mol Life Sci, 69, pp.763~781 (2012)
19. Kripke ML, "Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization", J Immunol, 145, pp.2833~2838 (1990)
20. Honda T, "Update of immune events in the murine contact hypersensitivity model : toward the understanding of allergic contact dermatitis", J Invest Dermatol, 133, pp.303~315 (2013)
21. Ring S, "CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue", Eur J Immunol, 36, pp.2981~2992 (2006)
22. Schwarz A, "Ultraviolet radiation-induced regulatory T cells not only inhibit the induction bur can suppress the effector phase of contact hypersensitivity", J Immunol, 172, pp.1036~1043 (2004)
23. Saraiva M, "The regulation of IL-10production by immune cells", Nat Rev Immunol, 10, pp.170~181 (2010)
24. Mosser MD, "Interleukin-10 : new perspectives on an old cytokine", Immunol Rec, 226, pp.205~218 (2008)
25. Saraiva M, "Identification of a macrophage-specific chromatin signature in the IL-10 locus", J Immunol, 175, pp.1041~1046 (2005)
26. Leus NG, "HDAC1-3 inhibitor MS-275 enhances IL10 expression in RAW264. 7 macrophages and reduces cigarette smoke-induced airway inflammation in mice", Sci Rep, 7, pp.45047~ (2017)
27. Wang H, "Histone deacetylase inhibitor LAQ824 augments inflammatory responses in macrophages through transcriptional regulation of IL-10", J Immunol, 186, pp.3986~3996 (2011)
28. Suraweera A, "Combination therapy with histone deacetylase inhibitors(HDACi)for the treatment of cancer : achieving the full therapeutic potential of HDACi", Front Oncol, 8, pp.92~ (2018)
29. Jespersen H, "Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma(PEMDAC study) : protocol for a multicenter phase II open label study", BMC Cancer, 19, pp.415~ (2019)
30. Yeruva SLH, "E2112 : randomized phase iii trial of endocrine therapy plus entinostat", placebo in patients with hormone receptor-positive advanced breast cancer, 2018, pp.4, 1~
31. McCaw TR, "Class I histone deacetylase inhibition promotes CD8 T cell activation in ovarian cancer", Cancer Med, 10, pp.709~171 (2020)
32. Zhang ZY, "MS-275, an histone deacetylase inhibitor, reduces the inflammatory reaction in rat experimental autoimmune neuritis", Neuroscience, 169, pp.370~377 (2010)
33. Zhang ZY, "HDAC inhibitor MS-275 attenuates the inflammatory reaction in rat experimental autoimmune prostatitis", Prostate, 72, pp.90~99 (2012)
34. Lucas JL, "Induction of Foxp3+regulatory T cells with histone deacetylase inhibitors", Cell Immunol, 257, pp.97~104 (2009)

관련 논문AI추천